Diamyd Inc: Clinical Trials

2 trials sponsored by Diamyd Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Diamyd Inc: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active GAD-alum injection - Type I Diabetes
Phase 1CompletedUniversity of Alabama at Birmingham1012015-01-012022-05-06
Gene Transfer for Cancer Pain
NP2 - Cancer Pain
Phase 1CompletedDiamyd Inc102008-02-012014-02-19

Conditions studied

Cancer Pain (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Pain (1)

Interventions

gamma-Aminobutyric Acid (1)

Countries

United States (2)

Top investigators

David J Fink, MD (1)  ·  Gail Mick, MD (1)  ·  Kenneth McCormick, MD (1)

Results publications

PMID 34228132, PMID 37509587